Zhejiang Huakang Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 1,358.54 million compared to CNY 942.97 million a year ago. Revenue was CNY 1,368.78 million compared to CNY 949.97 million a year ago.

Net income was CNY 185.18 million compared to CNY 141.94 million a year ago. Basic earnings per share from continuing operations was CNY 0.6231 compared to CNY 0.4769 a year ago. Diluted earnings per share from continuing operations was CNY 0.6231 compared to CNY 0.4769 a year ago.